Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continued to mutate and
spread in 2022 despite the introduction of safe, effective vaccines and medications. Vaccine�…

Background: The adoption of digital health care within health systems is determined by
various factors, including pricing and reimbursement. The reimbursement landscape for�…

Despite widespread mass rollout programs, the rapid spread of the SARS-CoV-2 Omicron
variant called into question the effectiveness of the existing vaccines against infection�…

Vaccination is the primary defense against severe acute respiratory syndrome coronavirus
2, especially among older adults and those with chronic conditions. Using a nationally�…

There is growing concern that Coronavirus Disease 2019 (COVID-19) vaccine fatigue will be
a major obstacle in maintaining immunity in the general population. In this study, we�…

Background Regular, detailed reporting on population health by underlying cause of death
is fundamental for public health decision making. Cause-specific estimates of mortality and�…

Background Detailed, comprehensive, and timely reporting on population health by
underlying causes of disability and premature death is crucial to understanding and�…

Targeted public health interventions for an emerging epidemic are essential for preventing
pandemics. During 2020-2022, China invested significant efforts in strict zero-COVID�…

It is unclear how great a challenge pandemic and vaccine fatigue present to public health.
We assessed perspectives on coronavirus disease 2019 (COVID-19) and routine�…

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as
nonalcoholic fatty liver disease (NAFLD), is a prevalent chronic liver disease worldwide�…